21 related articles for article (PubMed ID: 38486935)
1. Retraction: The novel tumor suppressor gene ZNF24 induces THCA cells senescence by regulating Wnt signaling pathway resulting in inhibition of THCA tumorigenesis and invasion.
Frontiers Editorial Office
Front Oncol; 2024; 14():1443826. PubMed ID: 38957314
[TBL] [Abstract][Full Text] [Related]
2. Akt Inhibition Enhanced the Growth Inhibition Effects of Low-Dose Heavy-Ion Radiation
Huang K; Zhao W; Wang X; Qiu Y; Liu Z; Chen R; Liu W; Liu B
Front Oncol; 2021; 11():649176. PubMed ID: 33869050
[TBL] [Abstract][Full Text] [Related]
3. Retraction: Exosomes from cancer-associated mesenchymal stem cells transmit TMBIM6 to promote the malignant behavior of hepatocellular carcinoma via activating PI3K/AKT pathway.
Frontiers Editorial Office
Front Oncol; 2023; 13():1307333. PubMed ID: 37927479
[TBL] [Abstract][Full Text] [Related]
4. Guggulsterone from Commiphora mukul potentiates anti-glioblastoma efficacy of temozolomide in vitro and in vivo via down-regulating EGFR/PI3K/Akt signaling and NF-κB activation.
Xu HB; Chen XZ; Yu ZL; Xue F
J Ethnopharmacol; 2023 Jan; 301():115855. PubMed ID: 36280019
[TBL] [Abstract][Full Text] [Related]
5. Retraction: MicroRNA-326 functions as a tumor suppressor in breast cancer by targeting ErbB/PI3K signaling pathway.
Frontiers Editorial Office
Front Oncol; 2023; 13():1298871. PubMed ID: 37881488
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of glycolytic metabolism in glioblastoma cells by Pt3glc combinated with PI3K inhibitor via SIRT3-mediated mitochondrial and PI3K/Akt-MAPK pathway.
Wang G; Fu XL; Wang JJ; Guan R; Sun Y; Tony To SS
J Cell Physiol; 2019 May; 234(5):5888-5903. PubMed ID: 29336479
[TBL] [Abstract][Full Text] [Related]
7. Progress in targeting PTEN/PI3K/Akt axis in glioblastoma therapy: Revisiting molecular interactions.
Hashemi M; Etemad S; Rezaei S; Ziaolhagh S; Rajabi R; Rahmanian P; Abdi S; Koohpar ZK; Rafiei R; Raei B; Ahmadi F; Salimimoghadam S; Aref AR; Zandieh MA; Entezari M; Taheriazam A; Hushmandi K
Biomed Pharmacother; 2023 Feb; 158():114204. PubMed ID: 36916430
[TBL] [Abstract][Full Text] [Related]
8. Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway.
Burris HA
Cancer Chemother Pharmacol; 2013 Apr; 71(4):829-42. PubMed ID: 23377372
[TBL] [Abstract][Full Text] [Related]
9. Retraction: Akt inhibition enhanced the growth inhibition effect of low-dose heavy-ion radiation via the PI3K/Akt/P53 signaling pathway in C6 glioblastoma cells.
Frontiers Editorial Office
Front Oncol; 2023; 13():1205993. PubMed ID: 38486935
[TBL] [Abstract][Full Text] [Related]
10. The Role of Micro RNAs in Regulating PI3K/AKT Signaling Pathways in Glioblastoma.
Ghaffarian Zirak R; Tajik H; Asadi J; Hashemian P; Javid H
Iran J Pathol; 2022; 17(2):122-136. PubMed ID: 35463721
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
